Age-related macular degeneration happens when part of the retina is damaged due to ageing complications. The condition is known to affect millions of people around the globe. It is fourth in the list of diseases that commonly lead to blindness behind cataracts, preterm birth and glaucoma.
Macular degeneration, also referred to as age-related macular degeneration (AMD), is a medical condition that results in blurred or total vision loss in the centre of a person’s visual field.
The macula is a small, but extremely important area located at the centre of the retina; the retina is the light-sensing tissue that lines the back of the eye. It is this area that is responsible for seeing details clearly.
A person with macular degeneration will retain normal peripheral vision. For example, when looking at a clock, they may see the outside but not the time.
In the early stages of the disease, there are often no symptoms. An individual will usually experience a gradual loss of their vision. Loss of vision may affect either one or both eyes.
Although the condition will not necessarily lead to total vision loss, weak central vision can make daily activities difficult. It will also make recognition of faces and objects more challenging. In addition to this, it is not uncommon for someone with AMD to experience hallucinations.
There are two types of macular degeneration known as ‘wet’ and ‘dry’. Most cases of AMD are dry.
With dry macular degeneration, the blood vessels in the eye do not leak. There are usually minimal symptoms in the early stages; however, it progressively worsens as time goes on. Vision loss tends to occur within the intermediate to late stages.
Dry AMD usually affects both eyes; however, in cases where only one eye is affected, vision changes are more noticeable sooner as one eye starts to make up for the vision loss in the other.
Wet AMD is when abnormal blood vessels grow in the eye and leak below the macula, resulting in permanent vision loss. It is a more advanced form of AMD, and dry AMD can progress to wet AMD.
The risk of macular degeneration increases with age and usually begins at the age of 50 and over. However, in some rare instances, the disease does affect younger people; this is called juvenile macular degeneration.
While the exact cause of AMD is unknown, several different risk factors can contribute to macular degeneration, including:
The symptoms of macular degeneration are similar to other eye conditions, making it difficult to detect initially. Early AMD is usually asymptomatic, meaning symptoms won’t be noticeable. It's advised you see an optician for diagnosis with an eye exam.
Symptoms may include any of the following:
Age-related macular degeneration can get worse and affect your vision. AMD's worsening can happen over several years or at a more rapid rate over a few weeks or months.
There is no treatment for dry AMD, but vision aids can help with lifestyle.
Wet AMD is usually treated with injections in the eye. These injections stop vision getting worse, but they will not recover visual acuity that has already been lost. Therefore, it’s essential to get treatment as soon as possible if you have been diagnosed with wet AMD.
According to reports by the American Optometric Association, it can take around ten years for people with AMD to experience complete vision loss.
Those with dry AMD will lose their vision gradually as the retinal cells die off. On the other hand, wet forms of macular degeneration can cause your vision to deteriorate at a rapid rate. Some even lose their sight within days of having symptoms.
There is no complete cure for age-related macular degeneration (AMD), although there are treatments that can slow the process. Different procedures are used to treat different types of AMD.
There is no treatment for dry AMD; however, visual aids can keep your vision sharp and eyes safe from dry eye, thus reducing its effect. These include large printed books, magnifying glasses, bright reading lights and smart screen reading software.
Also known as neovascular AMD, wet AMD relies on medications called anti-vascular endothelial growth factor drugs for treatment. These stop blood vessel growth which leads to sight damage.
The medication gets injected into the vitreous: a gel-like substance inside the eye. Before the injection, the doctor will give you an anaesthetic drug to ease pain and antibiotic drop to prevent infection.
Side effects include blurry vision for a short time after the injection. Injections are usually given in a course for one or a few months, at first.
Anti-VEGF medications have a high success rate. It would be best if you started treatment as early as possible as this treatment cannot repair underlying damage.
Occasionally Wet AMD is treated with 'photodynamic therapy', a light treatment that will prevent your vision problems from worsening.
It's important to have routine eye exams to identify early signs of macular degeneration. The following measures may help reduce your risk of developing dry macular degeneration:
Disclaimer: The advice in this article is for informational purposes only and does not replace medical care or an in-person check-up. Please check with an eyecare professional before purchasing any products or remedies. For information on our article review process, please refer to our Editorial Policy.